The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries
Abstract Background People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World Health Organization (WHO) adopted a st...
Main Authors: | M. Maticic, Z. Pirnat, A. Leicht, R. Zimmermann, T. Windelinck, M. Jauffret-Roustide, E. Duffell, T. Tammi, E. Schatz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | Harm Reduction Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12954-020-00439-3 |
Similar Items
-
Migration experiences, life conditions, and drug use practices of Russian-speaking drug users who live in Paris: a mixed-method analysis from the ANRS-Coquelicot study
by: Yaël Tibi-Lévy, et al.
Published: (2020-08-01) -
Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework
by: Ste.phanie Popping, et al.
Published: (2018-07-01) -
Improving HIV service delivery for people who inject drugs in Kazakhstan: study protocol for the Bridge stepped-wedge trial
by: Tara McCrimmon, et al.
Published: (2019-06-01) -
Young people who inject drugs in Mozambique: should we emphasize them in the National Harm Reduction Plan?
by: Cynthia Semá Baltazar, et al.
Published: (2020-03-01) -
‘This is hardcore’: a qualitative study exploring service users’ experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England
by: Fleur Riley, et al.
Published: (2023-05-01)